Aquire Wealth Advisors’s Edesa Biotech EDSA Stock Holding History

Aquire Wealth Advisors’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6	Closed	–	–	92
2021 Q4	$0	Buy	+6	New	+$287	﹤0.01%	252

Other funds holding EDSA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aquire Wealth Advisors's EDSA Position: Q1 2022 in Review

Aquire Wealth Advisors sold out of Edesa Biotech (EDSA) in Q1 2022, closing a stake of 6 shares.

Aquire Wealth Advisors first reported a position in EDSA in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 22 funds tracked by Wall St. Rank hold EDSA as of Q1 2022.

Aquire Wealth Advisors reported no remaining Edesa Biotech position as of Q1 2022 after selling out during the quarter.
Aquire Wealth Advisors sold 6 Edesa Biotech shares in Q1 2022.
Aquire Wealth Advisors first reported a position in Edesa Biotech in Q4 2021 and held it in 1 quarter.
Aquire Wealth Advisors's Edesa Biotech position peaked at $0 in Q4 2021.
22 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2022.

Based on Aquire Wealth Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.